T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy.
Stephen B, Hajjar J, Sarda S, Duose DY, Conroy JM, Morrison C, Alshawa A, Xu M, Zarifa A, Patel SP, Yuan Y, Kwiatkowski E, Wang L, Rodon Ahnert J, Fu S, Meric-Bernstam F, Lowman GM, Looney T, Naing A.
Stephen B, et al. Among authors: lowman gm.
J Immunother Cancer. 2023 Aug;11(8):e007236. doi: 10.1136/jitc-2023-007236.
J Immunother Cancer. 2023.
PMID: 37604642
Free PMC article.